glp-1 news today november 5 2025 Orforglipron, an Oral Small-Molecule Receptor Agonist for Obesity 5, DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied glp-1 news today november 5

High concentrations of glucose activate the K ATP -VDCC axis by increasing ATP production, and subsequent Ca 2+ influx possibly activates Adcy 1

PMS includes both physical symptoms, like bloating, headache, and breast soreness, and emotional symptoms such as mood swings, anxiety, and difficulty sleeping

PG-102 also reduced -cell area compared with vehicle and showed a trend toward lower levels than semaglutide or tirzepatide, suggesting decreased glucagon production (Fig

She will also make decisions about what cases are included in the lawsuit and what evidence is allowed to be used at trial

The 5-on-2-off schedule for GH secretagogues exists for a specific reason: maintaining receptor sensitivity

By the spring of 1984 Mojsov had developed a number of tools for testing out her hypothesis that GLP-1 (7-37) existed in the gut as well as in small quantities in the pancreas